These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
22 Apr, 2026, 10.08 PM IST
Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
08 Apr, 2026, 01.28 PM IST
Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...
26 Feb, 2026, 10.14 AM IST
CD&R makes Rs 2,983 cr open offer for 26% stake in Sanofi Consumer Healthcare IndiaGlobal investment firm CD&R announces an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India for up to Rs 2,983 crore. Th...
21 Oct, 2024, 08.32 PM IST
Sanofi in exclusive talks with CD&R over sale of $17 bn OpellaFrench pharmaceutical company Sanofi has entered exclusive talks to sell a 50% stake in its consumer health business Opella to U.S. private...
21 Oct, 2024, 01.09 PM IST
Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
13 Sep, 2024, 11.08 AM IST
Sanofi India decides to put headquarters in Mumbai on the blockSanofi's Indian subsidiary is planning to sell its 150,000 sq ft standalone property in Mumbai's Powai area, which serves as its current he...
11 Jul, 2024, 03.49 PM IST
Sanofi plans to split consumer health unit to narrow focusSanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a sep...
28 Oct, 2023, 12.32 AM IST
CORONA remedies buys Sanofi India's ortho brand MyorilAhmedabad-based pharmaceutical company CORONA Remedies has acquired the muscle relaxant brand Myoril from Sanofi India for Rs234 crore. The...
28 Jun, 2023, 07.22 PM IST
Sanofi reinvigorates India business, with eye on higher growthThe company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovati...
25 May, 2023, 03.09 PM IST
Sanofi India board OKs demerger of consumer health businessDrug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. Th...
11 May, 2023, 12.45 AM IST
Sanofi board approves demerger of its consumer healthcare businessThis decision will open new gates for the India business and employees in a value-driven move to accelerate growth for both the pharmaceuti...
10 May, 2023, 03.52 PM IST
French drugmaker Sanofi looks to spin off its consumer business in IndiaThe leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...
31 Mar, 2023, 08.02 AM IST
Sanofi names Rodolfo Hrosz as India unit headHrosz will transition from being Sanofi’s general manager, Consumer Healthcare business in Brazil to his new role in India as soon as the a...
18 Apr, 2022, 06.46 PM IST
Sanofi, Boehringer Ingelheim close business swap in IndiaSanofi is excited to embrace the incoming CHC brands and people associated with this business, as this is in line with objective of boostin...
01 Mar, 2017, 03.23 PM IST
- Sanofi to acquire Chattem, expand presence in US
Sanofi-aventis agreed to buy Chattem, the maker of Gold Bond medicated body powder, for $1.9 billion to enter the US consumer health care m...
22 Dec, 2009, 01.58 AM IST
- Sanofi-Aventis to buy Chattem for $1.9 bn
French drug maker Sanofi-Aventis SA to buy US health care company Chattem Inc for about $1.9 billion in cash.
21 Dec, 2009, 06.52 PM IST